Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,751Revenue $M42,750Net Margin (%)19.3Z-Score2.4
Enterprise Value $M130,589EPS $3.6Operating Margin %25.3F-Score7
P/E(ttm))13.8Cash Flow Per Share $0Pre-tax Margin (%)23.7Higher ROA y-yY
Price/Book10.510-y EBITDA Growth Rate %3.2Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %2.6Current Ratio1.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-11.2ROA % (ttm)11.7Higher Current Ratio y-yY
Dividend Yield %6.1Insider Buy (3m)0ROE % (ttm)74.0Less Shares Outstanding y-yY
Payout Ratio %81.0Shares Outstanding M2,402ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 43.61-20%Add 13358.6%4,949,118
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 43.61-20%Add 49.33%988,772
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 43.61-20%Add 15.52%2,500,048
GSKJames Barrow 2014-06-30 Buy 0.02%$51.55 - $56.39
($54.16)
$ 43.61-20%New holding, 270900 sh.270,900
GSKPRIMECAP Management 2014-06-30 Reduce-0.25%$51.55 - $56.39
($54.16)
$ 43.61-20%Reduce -43.82%5,156,449
GSKJohn Rogers 2014-03-31 Add0.16%$50.9 - $56.66
($54.07)
$ 43.61-19%Add 57.21%662,150
GSKHOTCHKIS & WILEY 2014-03-31 Buy 0.01%$50.9 - $56.66
($54.07)
$ 43.61-19%New holding, 36773 sh.36,773
GSKJohn Hussman 2014-03-31 Reduce-0.38%$50.9 - $56.66
($54)
$ 43.61-19%Reduce -23.61%323,500
GSKVanguard Health Care Fund 2014-03-31 Sold Out -0.11%$50.9 - $56.66
($54)
$ 43.61-19%Sold Out0
GSKNWQ Managers 2014-03-31 Reduce-0.03%$50.9 - $56.66
($54.07)
$ 43.61-19%Reduce -28.91%148,800
GSKJohn Hussman 2013-12-31 Add1.51%$49.31 - $53.68
($51.87)
$ 43.61-16%Add 1702.13%423,500
GSKJohn Rogers 2013-12-31 Add0.19%$49.31 - $53.68
($51.87)
$ 43.61-16%Add 208.93%421,201
GSKCharles Brandes 2013-12-31 Add0.16%$49.31 - $53.68
($51.87)
$ 43.61-16%Add 13.11%2,145,461
GSKJoel Greenblatt 2013-12-31 Buy 0.11%$49.31 - $53.68
($51.87)
$ 43.61-16%New holding, 83452 sh.83,452
GSKVanguard Health Care Fund 2013-12-31 Reduce-0.14%$49.31 - $53.68
($51.87)
$ 43.61-16%Reduce -55.18%644,881
GSKWarren Buffett 2013-12-31 Sold Out -0.02%$49.31 - $53.68
($51.87)
$ 43.61-16%Sold Out0
GSKJohn Rogers 2013-09-30 Add0.07%$50.27 - $52.96
($51.54)
$ 43.61-15%Add 246.35%136,344
GSKWarren Buffett 2013-09-30 Reduce-0.06%$50.27 - $52.96
($51.54)
$ 43.61-15%Reduce -76.57%345,819
GSKJohn Rogers 2013-06-30 Add0.03%$46.79 - $53.59
($50.77)
$ 43.61-14%Add 460.45%39,366
GSKJoel Greenblatt 2013-06-30 Sold Out -0.16%$46.79 - $53.59
($50.77)
$ 43.61-14%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GSK HOTCHKIS & WILEY 2014-06-304,949,1180.210.94+13358.6%
GSK James Barrow 2014-06-30270,9000.010.02New Buy
GSK John Rogers 2014-06-30988,7720.040.65+49.33%
GSK Charles Brandes 2014-06-302,500,0480.11.6+15.52%
GSK Ken Fisher 2014-06-3011,365,9030.471.3+1.35%
GSK Joel Greenblatt 2014-06-3083,52800.06+0.09%
GSK NWQ Managers 2014-06-30148,8500.010.08+0.03%
GSK John Hussman 2014-06-30323,5000.011.3
GSK Jean-Marie Eveillard 2014-06-30100
GSK Dodge & Cox 2014-06-3060,226,0502.513.1-0.27%
GSK Tweedy Browne 2014-06-30142,1180.010.16-0.34%
GSK PRIMECAP Management 2014-06-305,156,4490.210.3-43.82%
Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12263.92view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14211.93view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12263.92view

Press Releases about GSK :

    Quarterly/Annual Reports about GSK:

      News about GSK:

      Articles On GuruFocus.com
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Oct 17 2014 
      Dodge & Cox’ Stock Fund Third Quarter 2014 Commentary Oct 16 2014 
      Ebola: Is The Cure Out There? Oct 14 2014 
      Guru Stocks at 52-Week Lows: GE, BHP, TOT, BP, GSK Oct 12 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF Sep 30 2014 
      International Securities For A Diversified Income Portfolio Sep 23 2014 
      Widely Held Guru Stocks Trading In Europe Sep 22 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB Sep 21 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF Sep 16 2014 
      Guru Stocks at 52-Week Lows: GSK, VOD, LYG, EC, VALE Sep 08 2014 

      More From Our Partners
      Benzinga Weekly Preview: Earnings Season Is In Full Swing Oct 19 2014 - BENZINGA

      More From Other Websites
      The Zacks Analyst Blog Highlights: GlaxoSmithKline, NewLink Genetics, Allergan, Inovio... Oct 20 2014
      2 Numbers That Could Make GlaxoSmithKline plc A Spectacular Buy Oct 20 2014
      U.K.’s Glaxo Working to Accelerate Treatment for Ebola Virus Oct 18 2014
      GSK update on current development status of the GSK/NIH Ebola vaccine candidate Oct 18 2014
      Next week's earnings: Tech takes center stage Oct 17 2014
      CDC needs to get ahead of Ebola: Cramer Oct 16 2014
      Ebola: Is the world ready for the next pandemic? Oct 15 2014
      GlaxoSmithKline plc Is Becoming More Attractive By The Day Oct 15 2014
      Director/PDMR Shareholding Oct 14 2014
      GSK, REGN And SHPG, 3 Drugs Stocks Pushing The Industry Lower Oct 10 2014
      What Management Would Prefer You Didn’t Know About GlaxoSmithKline plc Oct 10 2014
      Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear Oct 09 2014
      S.Africa's Aspen, GSK team up to extend foothold in Japan Oct 09 2014
      Glaxo Agrees to Take 25% Stake in Aspen Pharmacare Japanese Unit Oct 09 2014
      Fast-tracking an Ebola vaccine may prove too slow Oct 07 2014
      [video] Obama: US working on Ebola screening Oct 07 2014
      Obama: US working on Ebola screening Oct 07 2014
      Battling Ebola Oct 07 2014
      [video] How prepared is US to contain Ebola? Oct 07 2014
      How prepared is US to contain Ebola? Oct 07 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK